Evidence map›Paper›PMID 37337139›Full record

ArticleBMC neurology2023

The SOS-SAH questionnaire in clinical practice: a multi-method evaluation study.

E Nobels-Janssen, I L Abma, I R de Ridder, R H L Haeren, M H Hertog, D Nanda, B van der Pol, W I M Verhagen, R H M A Bartels, P J van der Wees and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

E Nobels-JanssenDepartment of Neurology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands. edith.nobels-janssen@radboudumc.nl.
I L AbmaIQ healthcare, Radboud University Medical Center, Radboud Institute of Health Sciences, Nijmegen, the Netherlands.
I R de RidderDepartment of Neurology, Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
R H L HaerenDepartment of Neurosurgery, Maastricht University Medical Center, Maastricht, the Netherlands.
M H HertogDepartment of Neurology, Isala Hospital, Zwolle, the Netherlands.
D NandaDepartment of Neurosurgery, Isala Hospital, Zwolle, the Netherlands.
B van der PolDepartment of Neurosurgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
W I M VerhagenDepartment of Neurology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
R H M A BartelsDepartment of Neurosurgery, Radboud University Medical Center, Nijmegen, the Netherlands.
P J van der WeesIQ healthcare, Radboud University Medical Center, Radboud Institute of Health Sciences, Nijmegen, the Netherlands.
H D BoogaartsDepartment of Neurosurgery, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud University Nijmegen · NLIsala · NLMaastricht University · NLCanisius-Wilhelmina Ziekenhuis · NLElisabeth-TweeSteden Ziekenhuis · NLRadboud Institute for Molecular Life Sciences · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with mild disabilities after aneurysmal subarachnoid hemorrhage (aSAH), invisible symptoms might be easily overlooked during consultations in the outpatient clinic. We hypothesize that the Questionnaire for the Screening of Symptoms in aneurysmal Subarachnoid Hemorrhage (SOS-SAH), a disease-specific patient-reported outcome measure, might aid in screening for symptoms after aSAH. The objective of this explorative study is to evaluate the perceived impact of using the SOS-SAH in daily clinical practice for patients after aSAH, as well as to explore potential barriers to further implementation.

methodsThis multi-method study consists of a quantitative and a qualitative component. To evaluate differences in quality of care, a patient experience survey was sent to patients receiving usual care and to patients who received the SOS-SAH. A multiple linear regression model was applied, with the intervention group and case mix adjusters as independent variables. We described differences in the number of symptoms discussed between patients receiving usual care and those receiving care post-implementation. Following implementation, 16 patients and 6 healthcare professionals were interviewed about their perceptions concerning the impact of and barriers to using the SOS-SAH. A thematic analysis was performed to identify the main themes.

resultsThe survey did not reveal any differences between the usual-care group and the post-implementation group on the scales of the patient experience survey. After implementation of the SOS-SAH, the number of symptoms discussed during consultation did not increase. The interviews suggest that the SOS-SAH may improve the preparation of patients by providing them with greater insight into their complaints and by raising issues for the consultation. It could also enhance the structure and efficiency of consultation, in addition to improving communication about issues that matter to patients. All patients and healthcare professionals recommended continuing the use of the SOS-SAH in daily practice.

conclusionsAlthough no quantitative improvements were found in patient experience and symptoms discussed during consultation, implementation of the SOS-SAH could aid in screening for symptoms in patients after aSAH, and it might have a positive influence on patient preparation, while helping to structure consultations between patients and healthcare professionals.

Indexed as

Subarachnoid HemorrhageHumansMultivariate AnalysisSurveys and QuestionnairesAneurysmal subarachnoid hemorrhagePatient-reported outcome measureSOS-SAH

Identifiers

PMID37337139
PMCPMC10280905
OpenAlexW4381249706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.